Growth of the pharmaceutical consulting market in India is spurred by the rapid development of the pharmaceutical industry. India’s pharmaceutical sector, which is one of the largest global suppliers of generic drugs and vaccines, is set to reach $130 billion by 2030, creating a huge demand for consulting services that can bring strategic insights, regulatory compliance and operational efficiency. The key factors in this growth include the increasing complexity of global regulations, the emergence of more advanced technologies such as artificial intelligence and machine learning in... >>More
Venkatnarayanan K, Sr. Vice President & Head Customer Services Zone India, Siemens Healthineers
Dr. S. Eswara Reddy, Joint Drugs Controller (India), Central Drugs Standard Control Organisation (CDSCO)
Vinay Jain, Chief Operating Officer, Onelife Nutriscience
Dr. Shirish Alurkar, Sr. Consultant - Medical Oncology, HCG Cancer Centre